Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 4:03 PM
Ignite Modification Date:
2025-12-26 @ 4:03 PM
NCT ID:
NCT05688306
Eligibility Criteria:
Inclusion Criteria:
* Patients with pathological diagnosis of solid tumors or lymphomas.
* Have received chemotherapy.
* Diagnosed of CIT.
* Continuous use of platelet raising drugs for at least 5 days.
Exclusion Criteria:
* Thrombocytopenia caused other than chemotherapy, including but not limited to: traditional Chinese medicine, congenital platelet disease, etc.
* The basic value of platelet count is continuously higher than 300×10\^9/L.
* Those without blood routine or coagulation function data.
* Those who received non-chemotherapy drugs that may cause thrombocytopenia, such as sulfonamides.
* Pseudothrombocytopenia due to Ethylenediamine tetraacetic acid (EDTA) as an anticoagulant in test samples.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT05688306
Study Brief:
Protocol Section:
NCT05688306